OpenEvidence vs Hathr AI
AI Verdict
Choose OpenEvidence if…
Choose OpenEvidence if your primary need is immediate, evidence-based clinical decision support at the point of care, grounded in peer-reviewed medical literature. It excels at answering specific clinical questions, providing referenced answers from trusted sources like NEJM and JAMA, and can also assist with generating structured medical notes from patient visits.
View OpenEvidence →Choose Hathr AI if…
Choose Hathr AI if you require a highly secure, HIPAA-compliant AI platform for comprehensive data analysis, summarization of large documents, and generation of various clinical and administrative documents. It is particularly well-suited for tasks involving extensive patient data review, drafting pre-authorization letters, or creating SOAP notes, all within a FedRAMP High AWS GovCloud environment.
View Hathr AI →When choosing between OpenEvidence and Hathr AI, physicians should consider their primary need: evidence-based clinical answers or flexible, secure AI assistance for various tasks. OpenEvidence excels at providing immediate, referenced answers to clinical questions, drawing directly from a vast array of peer-reviewed medical literature and official guidelines. It is particularly strong for point-of-care decision support and offers integrated tools for transcribing patient visits and generating structured medical notes, making it ideal for physicians who prioritize rapid access to validated medical knowledge and streamlined documentation within their workflow. Its partnerships with major medical journals and its free access for verified U.S. healthcare professionals are significant advantages.
Hathr AI, on the other hand, offers a broader suite of HIPAA-compliant AI tools, focusing on secure data analysis, summarization of extensive documents, and versatile document generation. Hosted on AWS GovCloud and powered by Claude AI, it emphasizes privacy and security with zero data retention and a guaranteed Business Associate Agreement (BAA). While it can assist with clinical support and documentation, its core strength lies in handling and processing large volumes of patient data and generating various medical documents, such as pre-authorization letters or SOAP notes. The key practical difference is OpenEvidence’s specialization in evidence-based clinical answers versus Hathr AI’s general-purpose secure AI capabilities.
Therefore, a physician primarily seeking quick, referenced answers to clinical questions and integrated documentation support should lean towards OpenEvidence, especially given its free access. Conversely, a physician who requires a secure, versatile AI platform for summarizing large patient records, analyzing extensive documents, and generating a variety of medical correspondence, with a strong emphasis on data privacy and security, would find Hathr AI to be a more suitable choice, despite its subscription cost.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | OpenEvidence | Hathr AI |
|---|---|---|
| Pricing | Free | Paid plans start at $45/month. |
| Deployment | Cloud-based (web application) and mobile applications | Cloud-based (AWS GovCloud) |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
OpenEvidenceOpenEvidence is available as native iOS and Android apps and a web interface, described as clean and responsive, offering quick access and rapid answers. User reviews highlight its ease of use and efficiency in providing evidence-based answers. Hathr AI also offers a secure web platform and aims for ease of use, but lacks the extensive user reviews and specific UI/UX accolades of OpenEvidence.
Clinical Value
OpenEvidenceOpenEvidence provides AI-powered natural language question answering grounded in peer-reviewed medical literature from official partners like NEJM, JAMA, NCCN, and Cochrane, directly supporting clinical decision-making at the point of care. It also offers tools for transcribing patient visits and auto-generating medical notes. Hathr AI focuses on summarizing and analyzing patient data and generating documents, which are valuable administrative functions, but OpenEvidence's direct integration with extensive, authoritative medical literature for clinical queries provides a more direct clinical value.
Pricing & Value
OpenEvidenceOpenEvidence is free for verified U.S. healthcare professionals, making it highly accessible and a strong value proposition for individual clinicians. While it is ad-supported, this model allows for widespread adoption without direct cost to the user. Hathr AI has paid plans starting at $45/month, which, while offering robust features, presents a direct cost barrier that OpenEvidence avoids for its primary user base.
Enterprise Readiness
OpenEvidenceOpenEvidence offers enterprise pricing models for EHR integration and data insights subscriptions, and has demonstrated integration with EHR systems like Epic at Mount Sinai Health System. It also has a significant user base and established partnerships with major medical institutions. Hathr AI offers custom enterprise pricing and API access, and is hosted on AWS GovCloud with FedRAMP High environment, which is highly relevant for federal and defense healthcare, but OpenEvidence's proven EHR integration and widespread adoption in health systems suggest broader enterprise readiness for the general healthcare market.
Innovation
OpenEvidenceOpenEvidence demonstrates innovation through its AI-powered natural language question answering directly from peer-reviewed literature, its 'Visits' feature for real-time clinical decision support during documentation, and recent additions like voice mode and coding intelligence. Its focus on preventing AI hallucinations and maintaining transparent sourcing also highlights a commitment to responsible AI. Hathr AI's use of Claude AI with RAG for accuracy and its robust security posture are strong, but OpenEvidence's continuous development of direct clinical workflow enhancements and partnerships with leading medical journals position it as a leader in innovative clinical AI applications.
Support & Docs
TieBoth tools provide essential support. Hathr AI offers on-call support and AI training for enterprise plans, and a BAA signed within 24 hours. OpenEvidence provides a rich set of support and documentation resources, including developer resources for API integration, though detailed technical documentation is not publicly available. Without more specific comparative information on the breadth and responsiveness of their support channels or the depth of their documentation for all users, it's difficult to definitively pick a winner.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | OpenEvidence | Hathr AI |
|---|---|---|
| Company | OpenEvidence | Hathr AI |
| Tagline | America's Official Medical Knowledge Platform | HIPAA Compliant AI Tools for Healthcare |
| Core AI Functionality | AI-powered natural language question answering for clinical queries, answers grounded in peer-reviewed medical evidence, clinical decision support at the point of care, transcribes patient visits and auto-generates structured medical notes. | Secure data analysis, summarization of patient data and documents, document generation (e.g., pre-authorization, SOAP notes), and clinical support. |
| AI Model Used | AI-powered natural language processing (NPL) and retrieval-augmented generation-based Large Language Model (LLM) | Powered by Claude AI (with RAG for accuracy) |
| Key Data Sources/Evidence | Peer-reviewed medical evidence (NEJM, JAMA, NCCN, Cochrane, PubMed, Lancet, Nature) | Not specified, but optimized for healthcare terminology, billing codes, and clinical workflows |
| EHR Integration | Integrates with Electronic Health Record (EHR) systems like Epic | EHR integrations available with Enterprise plan |
Videos
Demos, reviews, and walkthroughs featuring OpenEvidence and Hathr AI.